A case of thrombotic microangiopathy (TMA) after transcatheter arterial chemoembolization for hepatocellular carcinoma using cisplatin-Reference-Cited by-同舟云学术

A case of thrombotic microangiopathy (TMA) after transcatheter arterial chemoembolization for hepatocellular carcinoma using cisplatin

Published:2017 Issue:6 Volume:58 Page:344-350
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Ohya Kazuki¹,Kawaoka Tomokazu¹,Nakahara Takashi¹,Nagaoki Yuko¹,Tsuge Masataka¹,Hiramatsu Ken¹,Imamura Michio¹,Kawakami Yoshiiku¹,Aikata Hiroshi¹,Miyama Takahiko²,Ichinohe Tatsuo²,Chayama Kazuaki¹

Affiliation:

1. Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University

2. Department of Hematology, Hiroshima University

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/58/6/58_344/_pdf

Reference9 articles.

1. 3) Kamada K, Nakanishi T, Kitamoto M, et al. Long-term Prognosis of Patients Undergoing Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Comparison of Cisplatin Lipiodol Suspension and Doxorubicin Hydrochloride Emulsion. J Vasc Interv Radiol 2001; 12: 847-854

2. 4) Watson PR, Guthrie TH Jr, Caruana RJ. Cisplatin-Associated Hemolytic-Uremic Syndrome Successful Treatment With a Staphylococcal Protein A Column. Cancer 1989; 64: 1400-1403

3. 5) Noris M, Remuzzi G. Atypical Hemolytic-Uremic Syndrome. N Engl J Med 2009; 361: 1676-1687

4. 6) George JN, Nester CM. Syndromes of Thrombotic Microangiopathy. N Engl J Med 2014; 371: 654-666

5. 9) Lechner K, Obermeier HL. Cancer-Related Microangiopathic Hemolytic Anemia Clinical and Laboratory Features in 168 Reported Cases. Medicine 2012; 91 (4): 195-205

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin;Reactions Weekly;2017-09